Mutations in CRBN and other cereblon pathway genes are infrequently associated with acquired resistance to immunomodulatory drugs

Jones, J. R.Barber, A.Le Bihan, Y-VWeinhold, N.Ashby, C.Walker, B. A.Wardell, C. P.Wang, H.Kaiser, M. F.Jackson, G. H.Davies, F. E.Chopra, R.Morgan, G. J.Pawlyn, C.2024-07-182024-07-182021Jones JR, Barber A, Le Bihan YV, et al. Mutations in CRBN and other cereblon pathway genes are infrequently associated with acquired resistance to immunomodulatory drugs. Leukemia. 2021;35(10):3017-3020. doi:10.1038/s41375-021-01373-4https://hdl.handle.net/1805/42312en-USAttribution 4.0 InternationalMultiple myelomaTumor biomarkersNeoplasm drug resistanceMutations in CRBN and other cereblon pathway genes are infrequently associated with acquired resistance to immunomodulatory drugsArticle